How to bid on BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response

What the agency is buying

The Department of Health and Human Services, through BARDA, is seeking contractors to provide vaccine medical countermeasures for pandemic influenza preparedness and response. This includes supplying influenza vaccines, antigens, and adjuvants for public health emergencies and to support improved vaccine development efforts.

Contractors will need to furnish all necessary services, qualified personnel, materials, supplies, equipment, and facilities. U.S. facilities are preferred. The work also involves supporting rapid regulatory decisions and manufacturing readiness by generating and submitting relevant data to the FDA.

Key dates and deadlines

The solicitation was published on September 11, 2026. All proposals must be submitted by November 20, 2026, at 5:00 PM ET. It is important to submit your response well before the deadline to avoid any last-minute technical issues.

Who this opportunity suits

This opportunity is suitable for firms with significant experience in influenza vaccine manufacturing. To be eligible, offerors must either hold a U.S. influenza vaccine license or have developed an influenza vaccine as evidenced by the submission of a Biologics License Application (BLA) for a seasonal or pandemic influenza vaccine.

This is a professional services contract in the medical countermeasures category, specifically targeting entities capable of producing vaccines against influenza and influenza strains with pandemic potential.

How to respond

To access the full solicitation details and proposal submission instructions, you need to view the original source on the portal. Click the “View original source” link. If the first click takes you to the portal’s homepage, click it again to go directly to the bid.

You may need to create a free account on the portal to view all the documents, though for some bids, this is not required. All necessary instructions and attachments (01-19) will be available there.

Tips for a competitive response

Carefully review all 19 attachments mentioned in the solicitation, as they contain critical details for your proposal. Ensure your proposal clearly demonstrates how your firm meets the mandatory qualification requirements, particularly regarding your U.S. influenza vaccine license or BLA submission.

Highlight your experience in manufacturing influenza vaccines and your capacity to provide qualified staff, materials, equipment, and facilities. Emphasize any capabilities that support rapid regulatory decisions and manufacturing readiness, as these are key aspects of the agency's requirements.